P.S.S.'s Approach to ASCs: A Natural Partnership

Ambulatory Surgery Centers (ASCs) represent one of the most dynamic and underserved segments in healthcare today. These facilities operate at the intersection of efficiency, cost-consciousness, and quality outcomes. These are values that align perfectly with P.S.S.'s core mission. Our business model isn't just compatible with ASC operations; it's purpose-built for them.

‍

ASCs have fundamentally transformed surgical care over the past two decades. Unlike hospital outpatient departments, ASCs are physician-owned or physician-led facilities designed around a simple principle: deliver high-quality care with operational efficiency and favorable economics. This model has proven remarkably resilient and increasingly attractive to both physicians and patients. ASCs handle roughly 50% of all outpatient surgeries in the United States, and that share continues to grow as reimbursement pressures mount and physicians seek greater autonomy over their practice environment.

However, ASCs face persistent challenges. Reimbursement rates remain squeezed by payers, supply chain costs are volatile, and regulatory requirements continue to tighten. Most critically, ASCs operate with razor-thin margins, often 5-10%, meaning that every operational decision carries outsized financial weight. Physicians who own or invest in ASCs need solutions that deliver measurable value without adding complexity or cost.

‍

This is where P.S.S.'s value proposition becomes compelling. Our Ultrathin electrode and related innovations address the specific pain points that keep ASC operators up at night.

Cost Efficiency Without Compromise: PSS delivers premium-quality urology electrodes at a fraction of OEM pricing, without the burden of long-term contracts or vendor lock-in. Our electrodes are cross-compatible with existing electrosurgical units (ESUs), meaning ASCs can achieve significant cost savings without capital expenditures on new equipment. For ASC administrators operating on tight margins, the combination of superior quality at lower cost, procurement flexibility, and equipment compatibility directly improves profitability and operational economics.

Physician-Centric Innovation: ASCs exist because physicians want more control over their practice environment and patient outcomes. P.S.S. was born from the same philosophy. We listen to physicians and solve real problems they face in the room. Our Ultrathin electrode wasn't designed by marketers in a conference room; it emerged from years of feedback from interventionalists who demanded better tools.

Capital-Light Adoption: Unlike many medical device companies that require significant infrastructure investments or training overhead, P.S.S. products integrate seamlessly into existing ASC workflows. Physicians can adopt our technology without extensive facility modifications, lengthy training programs, or disruption to their surgical schedule. This matters enormously in ASCs where capital expenditure approval moves quickly and operational continuity is paramount.

Alignment on Outcomes: ASCs are performance-driven ecosystems where reputation and outcomes directly impact market share and physician recruitment. PSS's approach aligns with how ASCs compete by providing tools and solutions that support efficient operations. ASCs benefit when they can streamline procedures, optimize scheduling, and maximize their financial returns.

‍

From a commercial perspective, P.S.S. 's model is tailor-made for ASC economics. ASCs operate with flat hierarchies and streamlined decision-making. A physician-partner or owner can evaluate P.S.S. technology, see the financial benefit, and implement adoption relatively quickly. There's no lengthy procurement process, no byzantine approval structure, no need to justify the purchase to a hospital administrator focused on different metrics.

Additionally, ASCs are increasingly consolidating into larger platforms and management service organizations (MSOs). This creates an opportunity for P.S.S. to establish preferred relationships with these groups, driving standardization across multiple facilities while maintaining the flexibility that individual physicians and centers demand.

‍

The ASC market is expanding, not contracting. More procedures migrate to the outpatient setting every year. More physicians are investing in ASC ownership. Reimbursement models increasingly favor lower-cost settings. This secular tailwind benefits any company that can help ASCs operate more efficiently and deliver better outcomes.

P.S.S. isn't chasing this trend, we're aligned with it. Our Ultrathin electrode and our approach to innovation speak directly to what ASC physicians and operators value: better tools and better economics. In an environment where every margin point counts and operational efficiency drives competitive advantage, P.S.S. delivers both.

‍